FierceHealthcare Announces Editorial Appointments and Promotions
April 26, 2018 09:26 ET
|
Questex LLC
WASHINGTON, April 26, 2018 (GLOBE NEWSWIRE) -- FierceHealthcare, a division of Questex LLC, today announced two new appointments: Tina Reed, executive editor, hospitals and health systems,...
FDA Accepts Veloxis’s Supplemental New Drug Application for the De Novo Indication for ENVARSUS XR®
April 19, 2018 17:57 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 11/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 19 April 2018 FDA Accepts Veloxis’s Supplemental New...
Veloxis Pharmaceuticals A/S Grants Warrants Under Existing Warrant Program
April 17, 2018 01:12 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 10/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 17 April 2018 Veloxis Pharmaceuticals A/S Grants Warrants Under...
Atlas Venture, F-Prime Capital Partners and SV Health Investors to Host Symposium Featuring Therapeutics Startup Ideas From World’s Top Academic Research Institutions
April 12, 2018 09:00 ET
|
SV Health Investors
CAMBRIDGE, Mass., April 12, 2018 (GLOBE NEWSWIRE) -- Boston-area venture capital firms Atlas Venture, F-Prime Capital Partners and SV Health Investors have partnered to create Science 2 Startup, an...
Syntel Partners with Esko for Life Sciences Labeling and Packaging Solutions
April 09, 2018 08:30 ET
|
Syntel, Inc.
TROY, Mich., April 09, 2018 (GLOBE NEWSWIRE) -- Syntel, Inc. (Nasdaq:SYNT), a leading global provider of integrated information technology and knowledge process services, today announced that it has...
Navigators and Protective Insurance Enter into Workers’ Compensation Underwriting Partnership
April 04, 2018 16:25 ET
|
The Navigators Group, Inc.
STAMFORD, Conn., April 04, 2018 (GLOBE NEWSWIRE) -- The Navigators Group, Inc. (NASDAQ:NAVG) and Protective Insurance (NASDAQ:BWINA) (NASDAQ:BWINB) today announced they have entered into an...
XOMA to Present at the H.C. Wainwright Global Life Sciences Conference
April 03, 2018 07:00 ET
|
XOMA Corporation
EMERYVILLE, Calif., April 03, 2018 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery, development and licensing of therapeutic antibodies, today announced that Jim Neal,...
Veloxis Appoints Morten Marott as Chief Financial Officer
April 02, 2018 23:13 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 08/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 03 April 2018 Veloxis Appoints Morten Marott as Chief Financial Officer Veloxis Pharmaceuticals A/S (OMX:...
Arbor Biotechnologies Discovers New CRISPR System Utilizing its Discovery Platform
March 15, 2018 12:00 ET
|
Arbor Biotechnologies Inc
Findings Published in the Journal Molecular Cell $15 Million Series A Financing to Scale Biodiscovery CAMBRIDGE, Mass., March 15, 2018 (GLOBE NEWSWIRE) -- Arbor Biotechnologies, an early stage...
Veloxis Files with FDA for the De Novo Indication for ENVARSUS XR
March 07, 2018 15:16 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 03/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 07...